News: Medicine

View:

1998

 

Found press releases

 

Getinge continues its investment in the bed management and pressure care

12/23/1998 4:53 AM EST  -   Getinge Group
market

Getinge Industrier today acquired the UK company Egerton
Hospital Equipment Ltd
Egerton - with its head office in Orpington, Kent - has a turnover of SEK
45 million and 72 employees. Egerton manufactures and markets
specialised beds and anti-decubitus mattresses for hospitals and nursing
homes. Anti-decubitus mattresses are used in the prevention and
treatment of bed...

Gambro signs a SEK 60 million Algerian contract

12/22/1998 8:37 AM EST  -   Gambro
Gambro has signed a SEK 60 million contract with IMC - Industries Medico
Chirurgicales in Algeria. The contract covers deliveries of at least 300
dialysis monitors with spare parts and water treatment equipment, during a
period of three years. This is a major break-through for Gambro in the
Algerian market. IMC has an exclusive contract with the government of Algeria
to supply hospitals and...

German Supreme Court to consider patent case

12/22/1998 3:13 AM EST  -   ASTRA
Södertälje, Sweden, December 22, 1998

GERMAN SUPREME COURT TO CONSIDER IMPORTANT PATENT CASE FOR ASTRA

The German Supreme Court will consider Astra's appeal concerning the
invalidation of a previously granted Supplementary Protection Certificate
(SPC) for the period 1999-2003 for the substance in the antipeptic ulcer
medication Losec (omeprazole). The SPC was granted in...

Astra gains approval for Muse across Europe

12/11/1998 7:37 AM EST  -   ASTRA
ASTRA GAINS APPROVAL FOR MUSE® ACROSS EUROPE

MUSE, a new local therapy for the treatment of impotence (erectile
dysfunction), was granted European Union mutual recognition approval on
December 1. The product has so far been launched in five countries, including
Sweden and the U.K.

A European study found MUSE to be effective in 64 percent of men with organic
...

Astra in agreement with schering-plough

12/9/1998 8:10 AM EST  -   ASTRA
® ®
ASTRA IN AGREEMENT WITH SCHERING-PLOUGH TO REACQUIRE LOSEC AND PERFUDAL
®
/PREVEX RIGHTS IN ITALY AND SPAIN

Astra AB and Schering-Plough Corporation today announced an agreement whereby
rights held by Schering-Plough's subsidiary, Essex Chemie, to market Losec
(omeprazole), an anti-peptic ulcer drug, and Perfudal/Prevex (felodipine), a
calcium...

Astra Zeneca

12/9/1998 3:03 AM EST  -   ASTRA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO
CANADA, AUSTRALIA OR JAPAN

ASTRA AND ZENECA IN MERGER OF EQUALS TO CREATE A GLOBAL LEADER IN PHARMACEUTICALS


Global power and reach in sales and marketing - number three worldwide and
strong presence in U.S. and Europe

Strong R&D platform for innovation-led growth - number three in R&D...

Astra and zeneca in merger discussions

12/8/1998 2:30 PM EST  -   ASTRA
Södertälje, Sweden, December 8, 1998

ASTRA AND ZENECA IN MERGER DISCUSSIONS

Following recent speculation, the Boards of Astra and Zeneca announce that
they are engaged in advanced discussions regarding a possible combination of
the two companies in a merger of equals transaction.
A further announcement will be made as soon as possible.

New Agreement Between Astra And Schering-plough

12/8/1998 8:43 AM EST  -   ASTRA
NEW AGREEMENT BETWEEN ASTRA AND SCHERING-PLOUGH REGARDING RIGHTS TO IMDUR® IN
THE U.S.

For some time Schering-Plough has been marketing the drug isosorbide-
5-mononitrate, with the trademark Imdur, in the U.S. market under license from
Astra. The product is used in the treatment of angina pectoris. This agreement
was valid until 2004. A new agreement has now been reached which entails...

Getinge executive management team expanded

12/1/1998 5:45 PM EST  -   Getinge Group
New Vice President of Business Area Sterilization Healthcare
Sven Kristensson, a former Vice President in the Åkerlund & Rausing group of
companies has been appointed new Vice President of Business area Sterilization
st
Healthcare, effective 1 December 1998. Sven Kristensson will be a member of
the Getinge executive management team.

Harald Castler has been...

Gambro sells COBE CV to Sorin

11/24/1998 2:12 AM EST  -   Gambro
Gambro has reached an agreement to sell the cardiopulmonary care products
company COBE CV to the Italian medical technology group Sorin. The sale is at
a price of 267 MUSD and generates a capital gain before tax for Gambro of
approx. 120 MUSD. The transaction is conditional upon approval by competition
authorities. The transaction is supposed to be closed during the beginning of
1999.